APA (7th ed.) Citation

N, J., M, K., O, Š., J, Z., S, L., S, S., . . . M, B. (2026). Identification and functional assessment of a KCNH2 compound heterozygosity in a patient with presumed idiopathic ventricular fibrillation ascertains the diagnosis of long QT syndrome type 2. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 28(2), . https://doi.org/10.1093/europace/euag001

Chicago Style (17th ed.) Citation

N, Janková, et al. "Identification and Functional Assessment of a KCNH2 Compound Heterozygosity in a Patient with Presumed Idiopathic Ventricular Fibrillation Ascertains the Diagnosis of Long QT Syndrome Type 2." Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology 28, no. 2 (2026). https://doi.org/10.1093/europace/euag001.

MLA (9th ed.) Citation

N, Janková, et al. "Identification and Functional Assessment of a KCNH2 Compound Heterozygosity in a Patient with Presumed Idiopathic Ventricular Fibrillation Ascertains the Diagnosis of Long QT Syndrome Type 2." Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, vol. 28, no. 2, 2026, https://doi.org/10.1093/europace/euag001.